Company / Free Cash Flow
Orchestra BioMed Holdings, Inc. Free Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$50.8M
FY2025
5-year range
-$50.8M / -$29.9M
FY2023-FY2025
Trend
-10.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$30M to -$51M over the past 2 years.
Based on SEC 10-K filings.
-$51M in FY2025.
Declined from -$30M to -$51M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 10.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$50.8M | -10.0% |
| FY2024 | -$46.2M | -54.6% |
| FY2023 | -$29.9M | - |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026